Classification
- Anatomical main groupSSensory organs
- Therapeutic subgroupS01Ophthalmologicals
- Pharmacological subgroupS01J
- Chemical subgroupS01JA
- Chemical substanceS01JA01Fluorescein
Where it is registered
Each register and historical list with its number of registrations and a few of them.
Canada
Health Canada · 19 registrations
- Diofluor Strips1 MG · Strip · Dioptic Pharmaceuticals INC
- Fluorescite10 % / W/V · Solution · Alcon Canada INC
- Minims Fluorescein Sodium2 % / W/V · Drops · Bausch & Lomb INC
- Fluorescein100 MG / ML · Solution · Pharma Stulln INC.
United States
FDA · 10 registrations
At a glance
- ATC code
- S01JA01
- ATC group
- Sensory organs
- Registers
- 5
- Historical lists
- 1
- Registrations
- 44
- With their own page
- 30
- Companies
- 21
All medicines with Fluorescein
Human medicines from every register that match Fluorescein by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
45 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Fluorescein | Canada | 100 MG / ML | Solution | Not marketed | Pharma Stulln INC. |
| Fluorescein Sodium | United States | 500MG BASE/2ML, 500MG BASE/5ML | injectable | Marketed | Nexus |
| Fluorescein Sodium and Benoxinate HydrochlorideCombination | United States | 0.4%; 0.3% | solution/drops | Marketed | Bausch Lomb Ireland |
| Fluoresceina Oculos 10% Solucion Inyectable | Spain | 500 mg | solución inyectable | Marketed | Serb Sa |
| Fluoresceinedinatrium 100 mg/ml, injectievloeistof | Netherlands | Oplossing voor injectie | Authorised | Fresenius Kabi Nederland B.V. | |
| Fluorescite | United States | 500MG BASE/5ML | injectable | Marketed | Alcon Labs INC |
| Odan-Fluorescein | Canada | 100 MG / ML | Solution | Not marketed | Odan Laboratoriesltd |
| Odan-Fluorescein | Canada | 250 MG / ML | Liquid | Not marketed | Odan Laboratoriesltd |
| Fluorescein Sodium & Benoxinate Hydrochloride Ophthalmic Solution, USPCombination | Canada | 0.4 % + 0.25 % | Solution | Not marketed | Bausch & Lomb INC |
| Minims Fluorescein Sodium | Canada | 2 % / W/V | Drops | Marketed | Bausch & Lomb INC |
| Ak-Fluor 10% | United States | 500MG BASE/5ML | injectable | Marketed | Long Grove Pharms |
| Minims Fluoresceina Sodica 20 MG/ML Colirio en Solucion | Spain | 20 ml | colirio en solución | Marketed | Bausch + Lomb Ireland Limited |
| Minims Lidocaine-Fluoresceine, oogdruppels, oplossingCombination | Netherlands | Oogdruppels, oplossing | Authorised | Bausch + Lomb Ireland Limited | |
| Ak-Fluor 25% | United States | 500MG BASE/2ML | injectable | Not marketed | Long Grove Pharms |
| Minims Fluoresceinenatrium 20 mg/ml, oogdruppels, oplossing | Netherlands | Oogdruppels, oplossing | Authorised | Bausch + Lomb Ireland Limited | |
| Minims Lidocaina/Fluoresceina 40 MG/ML + 2,5 MG/ML Colirio en Solucion en Envase UnidosisCombination | Spain | 0,04 g + 0,0025 g | colirio en solución en envase unidosis | Authorised | Bausch + Lomb Ireland Limited |
| Funduscein-25 | United States | 25% | injectable | Not marketed | Novartis |
| Minims Fluorescein Sodium 2% | Saudi Arabia | Authorised | Chauvin Bausch & Lomb | ||
| Fluorescite | Canada | 10 % / W/V | Solution | Marketed | Alcon Canada INC |
| MINIMS LIDOCAINE and FLUORESCEINCombination | Saudi Arabia | Authorised | Chauvin Bausch & Lomb | ||
| Fluorescite | New Zealand | Inj 10%, 5 ml vial | Funded | ||
| Altafluor BenoxCombination | United States | 0.4%; 0.25% | solution/drops | Marketed | Altaire Pharms INC |
| Fluorescite 100 mg/ml oplossing voor injectie | Netherlands | Oplossing voor injectie | Authorised | Alcon Nederland B.V. | |
| Odan-Fluorets | Canada | 1 MG | Strip | Not marketed | Odan Laboratoriesltd |
| Diofluor Strips | Canada | 1 MG | Strip | Marketed | Dioptic Pharmaceuticals INC |